US precision oncology biotech Stipple Bio has appointed Roland Gendron (pictured, above) as chief business officer as it prepares to move lead candidate STP-100 into early clinical studies. Mr Gendron ...
A precision-oncology biotech emerging from stealth with a $100 million Series A and an epitope-level targeting approach to antibody-drug conjugates designed to differentiate at the antibody-selection ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results